Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
N.H. committee hears bill to let medical dispensaries buy hemp-derived, nonintoxicating cannabinoids
Summary
Lawmakers heard testimony on House Bill 51 to let Alternative Treatment Centers (ATCs) purchase hemp-derived nonintoxicating cannabinoids (for example CBD) from third parties, with testing and a 0.3% THC cap. Supporters say it could lower costs and expand therapeutic options; opponents raised federal-state legal questions.
CONCORD — Lawmakers on the House Committee on Health, Human Services and Elderly Affairs heard testimony on House Bill 51, which would allow New Hampshire licensed alternative treatment centers (ATCs) to purchase hemp-derived, nonintoxicating cannabinoids from third-party producers for use in therapeutic products, while requiring testing and a 0.3 percent THC cap.
The bill’s prime sponsor, Representative Wendy Thomas of Merrimack, told the committee HB 51 would let ATCs purchase commercially produced hemp oils and concentrates that are high in nonintoxicating cannabinoids such as CBD so dispensaries can make a wider range of therapeutic products and potentially reduce costs for patients. “Essentially, this bill would allow ATCs to buy 3rd party hemp products containing non intoxicating cannabinoids to use in their products,” Thomas said.
Why it matters: Supporters said some patients seek products that are higher in CBD…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
